Company: SVREW
Filing Date: 2025-03-31
Form Type: F-1
Source: 0001213900-25-026272
Chunk: 19

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-31
Form: F-1
Chunk 19
---
 sales. |
| ● | Investors who buy ADSs                                                                                                          
 at different times will likely pay different prices.                                                                            |

| ● | We may require additional                                                                                                               
 financing to sustain our operations and without it we will not be able to continue operations.                                          |
| ● | The sale of a substantial amount of our Ordinary Shares or ADSs, including                                                              
 the resale of the shares held by the Selling Shareholder in the public market could adversely affect the prevailing market price of our 
 ADSs.                                                                                                                                   |

<div align='center'>5</div>

Implications of Being an Emerging Growth Company and a Foreign Private Issuer We are an “emerging growth company” as defined in the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other burdens that are otherwise applicable generally to public companies. These provisions include:

| ● | to the extent that we no                                                                                                             
 longer qualify as a foreign private issuer, (i) reduced disclosure obligations regarding executive compensation in our periodic      
 reports and proxy statements and (ii) exemptions from the requirement to hold a non-binding advisory vote on executive compensation, 
 including golden parachute compensation;                                                                                             |

| ● | an exemption from the auditor                                                                                                    
 attestation requirement in the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 
 2002; and                                                                                                                        |

We intend to take advantage of these exemptions for up to five years or until such earlier time that we are no longer an emerging growth company. We would cease to be an emerging growth company upon the earliest to occur of: (i) the last day of the fiscal year in which we have total annual gross revenues of $1.235 billion or more; (ii) the date on which we have issued more than $1.0 billion in nonconvertible debt during the previous three years; (iii) the date on which we are deemed to be a large accelerated filer under the rules of the SEC; or (iv) the last day of the fiscal year following the fifth anniversary of our IPO (i.e., December 31, 2027). We may choose to take advantage of some but not all of these exemptions. We are also considered a “foreign private issuer.” Even after we no longer qualify as an emerging growth company, as long as we qualify as a foreign private issuer under the Exchange Act, we will be exempt from certain provisions of the Exchange Act that are applicable to United States domestic public companies, including:

| ● | the